Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook 
World game at war: why some European nations have threatened a World Cup boycott 
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
Hong Kong, April 19, 2018 -- Dragon Jade International Limited (OTCQX: DGJI),a developer and marketer of next generation herbal and nutritional products and a supplier of medical devices and related services, today announcedthe initiation of a healthcare training division to address the growing opportunity the company believes exists in China as a result of the announcement in October of 2016 of Healthy China 2030.
The Healthy China 2030program is extending healthcare facilities from China’s largest cities to the entire nation’s population of 1.4 billion. Due to the rapid expansion of the healthcare sector, the company believes skill shortages are intensifying, as the existing level of trained staff and training facilities struggle to keep up with the rate of expansion.
Service providers globally have sought to access the opportunity to provide trained staff and training. The language barrier, cultural differences and the sheer size of the market have limited the abilities of such international service providers to address the market.
Dragon Jade is launching this new business to provide training and staffing to the Chinese healthcare market. The Company will utilize its access to medical professionals, experienced in both Western and Chinese medicine, from Hong Kong and Taiwan, who possess the necessary language and cultural skills to provide staffing solutions to the increasing numbers of China’s healthcare facilities. The Company plans to run specialist classes and training courses with support from its network of industry experts. Further, the Company will act as a conduit for well-known foreign medical schools and healthcare institutions to bring their procedures and products into the Chinese market.
Dragon Jade is in negotiations to use a facility in Guangdong Province, in southern China, as its first training center. Dragon Jade is in discussions with various other centers and potential partners in different locations in China to launch additional training centers. The centers are intended to be a platform for the Company to showcase its products and services in China.
Additionally, Dragon Jade is exploring remote training options, including virtual and augmented reality systems, which would enable training of larger numbers of people in more distant locations, using fewer teachers.
Dr. Steve Lai, CEO of the Company, commented: “The opportunity to provide both basic and advanced medical training in China will continue to grow as healthcare is rolled out across China, and as the expectations and ability to pay for better and more specialist treatment increases.”
About Dragon Jade
Dragon Jade International Limited (OTCQX: DGJI) is an Asian headquartered international healthcare group. With significant experience and contacts in the Greater China healthcare sector, the Group is focused on identifying, developing and marketing products from around the world in the Greater China market, and applying its international experience, network and access to experts, products and services in the fast-growing China market.
The Group has a particular strength in next generation herbal and natural products, leveraging proven resources to enhance and realize the commercial potential of herbal and biotechnological discoveries. The Group continues to develop, partner with and seek out cost-effective healthy living products.
Safe Harbor Statement
This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as the Company "believes," "expects," "anticipates," "foresees," "estimates," or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions, or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Contact: Investor Relations: PCG Advisory Group P: +1 646.863.7997 Corporate Relations Department Dragon Jade International [email protected] (+852) 2695-6999 www.dgjigroup.com
